Inflammatory Breast Cancer in Pregnancy and Lactation

Linhares, Samantha M.; Alrammah, Tamrah; Alghamdi, Hattan; Möller, Mecker G.

doi:10.1007/978-3-030-41596-9_20

Cited by 5 publications

(3 citation statements)

References 42 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Most importantly, IBC is a NIH-designated cancer health disparity ( Institute, 2016 ) with increased global incidence and mortality in minoritized and marginalized populations ( Relation et al, 2021 , Schinkel et al, 2014 , Gudina et al, 2019 ). This is consistent with reports of distinct reproductive risk factors like younger age at first pregnancy, multiparity, and breastfeeding in IBC ( Fouad TM, 2018 ) ( Linhares et al, 2020 , Mejri et al, 2020 ). These studies highlight the significance of primary care providers (PCP), including physicians, physician assistants, and nurse practitioners, who are often the first point of contact when patients begin to notice symptoms ( Nekhlyudov et al, 2017 ).…”

Section: Introductionsupporting

confidence: 92%

Identification of barriers at the primary care provider level to improve inflammatory breast cancer diagnosis and management

Devi,

Fish,

Bennion

et al. 2023

Preventive Medicine Reports

View full text Add to dashboard Cite

Section: Introductionsupporting

confidence: 92%

Identification of barriers at the primary care provider level to improve inflammatory breast cancer diagnosis and management

Devi,

Fish,

Bennion

et al. 2023

Preventive Medicine Reports

View full text Add to dashboard Cite

“…Тот же муцин экспрессируется и опухолевыми клетками некоторых видов злокачественных новообразований (к примеру, молочной железы, яичников) и опосредует рост и развитие данных клеток. В крови беременных и кормящих женщин были определены достаточно высокие титры иммуноглобулинов M и G к данному гликопротеину, что в теории может способствовать активному и эффективному противоопухолевому ответу и открывает новые возможности для новых подходов к иммунотерапии определенных злокачественных новообразований [23][24][25].…”

Section: клинический случай | Clinical Caseunclassified

Combination of pregnancy and breast cancer

Chernyshova,

Chernyakov,

Garbukov

et al. 2023

Opuholi ženskoj reproduktivnoj sistemy

View full text Add to dashboard Cite

Breast cancer (BC) occupies the second place in terms of incidence and the first ranking place in terms of mortality among oncopathology in women. The article presents the current state of the problem of the combination of BC and pregnancy, the impact of pregnancy on the course and outcome of breast oncopathology, as well as modern hypotheses for the development of breast cancer during pregnancy. It is shown that the current studies are quite contradictory and in many ways not accurate enough in methodology and materials. We present a clinical case of BC associated with pregnancy. The case is interesting from 2 positions: on the one hand, the patient’s tumor process is associated with pregnancy, on the other hand, there is a very rare combination of HER2/neu- and BRCA1-positive status.According to the presented literature data and our own data, it was concluded that the treatment of patients with BC during pregnancy is a difficult task and is often accompanied by tumor progression, despite the standard treatment regimens. Undoubtedly, this group of patients needs to develop new methodological approaches to antitumor treatment based on a deep analysis of the molecular genetic characteristics of the tumor, the hormonal background in general, and its effect on the tumor process during pregnancy. Such a personalized approach will improve the results of treatment of young patients with BC during pregnancy.

show abstract

“…diagnosis, is larger in size, has a higher frequency of nodal involvement, less frequently expresses estrogen receptors (ERs) and progesterone receptors (PRs), and is more likely to be inflammatory breast cancer (28).…”

Section: Reviewmentioning

confidence: 99%